
        <!DOCTYPE html>
        <html>
        <head>
            <title>Rocket Pharmaceuticals Inc. (RCKT) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Rocket Pharmaceuticals Inc. (RCKT)</h1>
                    <a href="index.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">15</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">3</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">6</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">-0.13</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=15fd282a3b574648ca2ed054fc3f40c7ebca3a42debdc44a148d3c578fe58bb7" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., August 28, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disord...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a353c3725bbc30ec933a91151b4777daf047f62e1a34bd7a412df26421386795" target="_blank" rel="noopener noreferrer">Rocket to relaunch rare disease trial after FDA approval</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The Phase II trial, which was placed on hold due to a patient death, will now resume with a reduced dose and altered regimen....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=11e373eed425d573dda15c3077bcbc414fbb870ac9c7231c393014390335717e" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.31
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d3cf1b3325f67b327fe759009e7ea42f7f7ef0da61738670e4eff8bdf81fbc04" target="_blank" rel="noopener noreferrer">RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.24
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals' shares soar as the FDA lifts its clinical hold on the pivotal Danon disease gene therapy study....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2cc252aeaf1e733d3218cc3423b040826e75d1f440766744aacbb3653c06e6f4" target="_blank" rel="noopener noreferrer">Rocket can resume gene therapy trial after FDA lifts hold</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died earlier this year....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7a2d619d60602a79790f62cd7e2137f549a684ec7ae42dcb6a7544758421e812" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.80
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., August 20, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disord...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aa7c597b3a874895d89c71b79fbbc4cd948752535a94bb27795f1c0eada108f8" target="_blank" rel="noopener noreferrer">Traders Digest Retail Earnings Ahead of Fed Minutes, Driving Muted Premarket Action for US Equity Futures</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.24
                                </span>
                            </div>
                            <div class="article-summary">US equity futures were little changed ahead of Wednesday's opening bell as traders digested earnings...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0544280f11c3b3891fff5fa67ce4c9d688586a3968122265073f93dcf9dde7c8" target="_blank" rel="noopener noreferrer">BC-Most Active Stocks</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">QMMM Holdings Ltd. 8,282,560 3.20...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2cc71f36e91125a49fd18dcb07fd47dbd24d1c1778c56c3fca4263f3926eb22f" target="_blank" rel="noopener noreferrer">Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.85
                                </span>
                            </div>
                            <div class="article-summary">The biotech  Rocket Pharmaceuticals  said the Food and Drug Administration would allow it to continue a gene therapy trial the agency had put on hold in late May, when a patient in the trial died.  In...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=61acd0ea72d0b0c24cff96d25925e48f69c13d547f6bac931d68da7d873a9c31" target="_blank" rel="noopener noreferrer">Jefferies Raises PT on Rocket Pharmaceuticals, Inc. (RCKT) to $3.00; Maintains ‘Hold’ Rating</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.84
                                </span>
                            </div>
                            <div class="article-summary">With significant hedge fund interest and a share price under $10, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) secures a spot on our list of the 11 Best Single Digit Stocks to Buy According to Hedge Fun...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=654295e3fab210bfeb438613cbfdbdb299712a414eb5f9dc89cde8f3ea228023" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Reorganizes, Cuts Workforce by 30% to Focus on AAV Cardiovascular Platform</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.06
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the most promising penny stocks under $5. On July 24, Rocket Pharmaceuticals announced a strategic corporate reorganization and pipeline prioritizat...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=00aeb3d3e9fce51646d7a80c30f4c501b5943f4add74cd6bcc07e5ccaedd73e3" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAE</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals is down 85% as key programs face FDA setbacks, despite a cash runway to 2027 and in vivo promise. Read why RKLB stock is a hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ee04f6d7ea12909507919ac01444f87899833fb75421bf225ed78efb9fc73a6a" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.35
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3352ea14f038977b88d887227b05415bc27babd646b85f5243f255af17268598" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., August 07, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disord...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3108cbc48ef6e871ca7b2a47941900ff380fec4da6d1c6aa8ea1e59f53fb1037" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals: Q2 Earnings Snapshot</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.78
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J. (AP) — Rocket Pharmaceuticals Inc. RCKT) on Thursday reported a loss of $68.9 million in its second quarter. The Cranbury, New Jersey-based company said it had a loss of 62 cents per sh...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        